QT dispersion and prognosis after coronary stent placement in acute myocardial infarction

Hiroyasu Ueda1, Tomoshige Hayashi, Kei Tsumura

  • 1Department of Cardiology, Ishikiriseiki Hospital, Osaka, Japan. hiroyasu-sayaka@joy.ocn.ne.jp

Clinical Cardiology
|May 12, 2007
PubMed

Insights

Corrected QT dispersion before percutaneous coronary intervention (PCI) predicts major adverse cardiac events and mortality in acute myocardial infarction (AMI) patients. QT dispersion 24 hours post-PCI did not show this association.

Area of Science:

  • Cardiology
  • Electrophysiology
  • Clinical Research

Background:

  • QT dispersion is elevated in acute myocardial infarction (AMI).
  • The prognostic value of QT dispersion post-AMI requires further elucidation.

Purpose of the Study:

  • To prospectively assess if QT dispersion correlates with major adverse cardiac events (MACE) and mortality risk after successful coronary stenting in AMI patients.

Main Methods:

  • 142 AMI patients undergoing successful percutaneous coronary intervention (PCI) were studied.
  • Corrected QT dispersion was measured before and 24 hours after PCI.

Main Results:

  • During follow-up, 21 MACE occurred.
  • Corrected QT dispersion before PCI independently predicted MACE and mortality (HR 2.24 for MACE, 2.71 for mortality per 1 SD increase).
  • Corrected QT dispersion 24 hours post-PCI was not significantly associated with MACE or mortality.

Conclusions:

  • Pre-PCI corrected QT dispersion is a significant predictor of adverse outcomes in AMI patients undergoing successful stenting.
  • Post-PCI QT dispersion does not appear to hold the same prognostic value.
Abstract

Related Concept Videos

Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome V: Nursing Management01:26

Acute Coronary Syndrome V: Nursing Management

Nursing Assessment:Nursing management of acute coronary syndrome (ACS) involves taking the patient's history, focusing on primary complaints such as chest pain, dyspnea, and excessive sweating (diaphoresis), as well as other symptoms like back or jaw pain, nausea, vomiting, palpitations, dizziness, and fatigue. The nurse also reviews the patient's history of cardiac events, risk factors such as hypertension, diabetes, smoking, family history, and current medications.In the objective assessment,...